CSIMarket Company Name, Ticker, Industry, else..
 
Amicus Therapeutics inc   (NASDAQ: FOLD)
 

Amicus Therapeutics Inc's Suppliers Performance

FOLD's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
FOLD Costs vs Sales of Suppliers Growth Amicus Therapeutics Inc recorded an increase in cost of sales by 80 % year on year, sequentially cost of sales grew by 42.11 % in Q4.

• More on FOLD Suppliers



Amicus Therapeutics Inc recorded increase in cost of sales by 80 % year on year, sequentially cost of sales grew by 42.11 % in Q4.

• More on FOLD Suppliers




Amicus Therapeutics Inc's Comment on Supply Chain


The company utilizes contract manufacturers to supply active biopharmaceutical ingredients and finished products for its offerings and product candidates. These ingredients and final formulations are produced in compliance with current Good Manufacturing Practice (cGMP). The components used are commonly found in other biopharmaceutical products and are well characterized. The company employs personnel with extensive manufacturing and quality experience to oversee contract manufacturers and has implemented controls to ensure quality. Product specifications are established in coordination with regulatory authorities during product registration. Existing agreements with third-party manufacturers provide sufficient quantities to meet anticipated clinical and commercial requirements.

Amicus Therapeutics Inc's Comment on Supply Chain


The company utilizes contract manufacturers to supply active biopharmaceutical ingredients and finished products for its offerings and product candidates. These ingredients and final formulations are produced in compliance with current Good Manufacturing Practice (cGMP). The components used are commonly found in other biopharmaceutical products and are well characterized. The company employs personnel with extensive manufacturing and quality experience to oversee contract manufacturers and has implemented controls to ensure quality. Product specifications are established in coordination with regulatory authorities during product registration. Existing agreements with third-party manufacturers provide sufficient quantities to meet anticipated clinical and commercial requirements.







FOLD's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Amicus Therapeutics inc 4,468.19 632.83 -27.11 511
SUBTOTAL 0.00 0.00 0.00 -


Sources: Amicus Therapeutics inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Amicus Therapeutics inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.